QA: Fibrocell Science Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000357097_2019_Fibrocell_Science_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.0025769289070789753, 'aggregate_val': 13160000, 'exp_sum': 13194000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 6405000, 'ResearchAndDevelopmentExpense': 6018000, 'remainder_Expenses': 771000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000357097')"}

Graph

Absolute values for 0000357097, Fibrocell Science Inc.

  xvar xval
0 AssetsCurrent 14,535,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,222,000
3 remainder_Assets 1,000
4 LiabilitiesCurrent 2,172,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 4,029,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,405,000
9 ResearchAndDevelopmentExpense 6,018,000
10 remainder_Expenses 737,000
11 remainder_Revenues 0
12 remainder_NetIncome 2,921,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,758,000
1 Liabilities 6,201,000
2 Expenses 13,160,000
3 Revenues 0
4 StockholdersEquity 9,557,000
5 NetIncome -10,239,000
6 ComprehensiveNetIncome -10,239,000
7 BaseVar 19,020,000
8 EconomicCapitalRatio 0.565

Edgar->Model Mapping

Feature Distribution

Change over Time